WorldCB & CDx Summit

<p><!-- wp:paragraph --></p> <p>Fueled by <strong>$60B+ in diagnostic deal-making</strong>, the <strong>16th World Clinical Biomarkers & Companion Diagnostics Summit</strong> returns as the industry’s premier end-to-end precision medicine forum convening <strong>850+ senior leaders</strong> from biopharma, diagnostics, regulatory, healthcare, and testing labs for the insights and partnerships driving clinical and commercial success.</p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p>Precision medicine is shifting into a new gear. As the FDA’s approach to LDTs and 510(k) pathways evolves, Rx-Dx launches accelerate, ctDNA and MRD advance as clinical endpoints, and reimbursement expands access to genomic testing, innovation across multi-omics, liquid biopsy, digital pathology, spatial biology, and AI-powered diagnostics is reshaping the IVD landscape.</p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p><!-- /wp:paragraph --></p>